Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Neutropenia and sepsis].
Kochanek M, Böll B, Hallek M, von Bergwelt-Baildon M. Kochanek M, et al. Among authors: boll b. Internist (Berl). 2013 Sep;54(9):1061-9. doi: 10.1007/s00108-013-3258-z. Internist (Berl). 2013. PMID: 23974912 German.
Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Teschner D, Berisha M, Panse J, Schmitt T, Fiegle E, Naendrup JH, Neitz J, Schmidt-Hieber M, Hentrich M, Böll B, Schalk E. Teschner D, et al. Among authors: boll b. Eur J Haematol. 2023 Dec;111(6):914-921. doi: 10.1111/ejh.14098. Epub 2023 Sep 13. Eur J Haematol. 2023. PMID: 37705250
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.
Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP, Rothe A, Böll B, Simhadri VL, Borchmann P, McKinnon PJ, Hallek M, Engert A. Pogge von Strandmann E, et al. Among authors: boll b. Immunity. 2007 Dec;27(6):965-74. doi: 10.1016/j.immuni.2007.10.010. Epub 2007 Dec 6. Immunity. 2007. PMID: 18055229 Free article.
[Hematologic and oncologic emergencies].
von Bergwelt-Baildon M, Böll B, Shimabukuro-Vornhagen A, Kochanek M. von Bergwelt-Baildon M, et al. Among authors: boll b. Med Klin Intensivmed Notfmed. 2013 Apr;108(3):184-90. doi: 10.1007/s00063-012-0176-0. Epub 2013 Mar 2. Med Klin Intensivmed Notfmed. 2013. PMID: 23455441 Review. German.
[Intensive care in oncology].
Kochanek M, Wendtner C, Shimabukuro-Vornhagen A, Böll B, von Bergwelt-Baildon M. Kochanek M, et al. Among authors: boll b. Dtsch Med Wochenschr. 2014 Apr;139(14):690-2. doi: 10.1055/s-0034-1369854. Epub 2014 Mar 12. Dtsch Med Wochenschr. 2014. PMID: 24623358 German. No abstract available.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, Fuchs M, Topp MS, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann HW, Schalk E, Semrau R, Kriz J, Vieler T, Bentz M, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause SW, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft Medikamentöse Tumortherapie. Behringer K, et al. Among authors: boll b. Lancet. 2015 Apr 11;385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22. Lancet. 2015. PMID: 25539730 Clinical Trial.
[Mortality of hematology-oncology patients with neutropenia in intensivecare].
Suárez I, Böll B, Shimabukuro-Vornhagen A, Michels G, von Bergwelt-Baildon M, Kochanek M. Suárez I, et al. Among authors: boll b. Med Klin Intensivmed Notfmed. 2016 Mar;111(2):84-91. doi: 10.1007/s00063-015-0039-6. Epub 2015 May 21. Med Klin Intensivmed Notfmed. 2016. PMID: 25994843 German.
153 results